XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (Loss) $ 639,974 $ (1,072,535)
Adjustments to reconcile net (loss) to net cash (used) by operating activities    
Change in fair value of derivative liability 48,192
Bad debt recovery (38,027)
(Gain) loss on discontinued operations and disposal (691,425) (26,807)
Amortization of debt discount 81,558
Loss on settlement of notes and other payables 553,222
Stock compensation expense 190,188
Issuance of warrants for services
Changes in Assets and Liabilities    
Trade accounts receivable 42,391 69,881
Other receivables
Product deposit (20,492)
Inventory 80,084 13,680
Other current assets (51,735)
Accounts payable and accrued expenses (73,357) (178,222)
Net cash (used) by operating activities of continuing operations (74,560) (358,870)
Net cash used in operating activities of discontinued operations 140,488 (114,386)
Net cash (used in) provided by operating activities 65,928 (473,256)
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from sale of legacy business 190,000
Net cash provided by (used in) investing activities 190,000
CASH FLOWS FROM FINANCING ACTIVITIES    
Investment in subsidiary by noncontrolling interest, net 43,378
Proceeds from notes payable 235,000
Proceeds from convertible note payable
Repayment of convertible note payable (100,000)
Repayment of notes payable (167,479) (151,420)
Proceeds from options exercise
Sale of common stock and warrants 647,944
Purchase of treasury stock (3,151)
Net cash provided by financing activities (167,479) 671,751
Net increase in cash 88,449 198,495
Cash at beginning of the period 141,379 182,561
Cash at end of the period 229,828 381,056
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest 4,383 3,612
Issuance of company stock for notes and other payables 192,192
Retirement of stock 375,687
Stock repurchase from shareholder 375,687
Conversion of liability as consideration on sale of legacy business 150,000
Conversion of equity invested in subsidiary to common stock and warrants 272,203
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance $ 1,569,444